三七总皂苷缓释片治疗心脑血管疾病患者的临床效果

The Clinical Effect of Total Saponins of Panax Sustained-release Tablets in the Treatment of Cardiovascular and Cerebrovascular Disease Patients

目的探讨三七总皂苷缓释片治疗心脑血管疾病的临床效果。方法选择2011年10月~2014年10月我院收治的心脑血管疾病患者90例,分为试验组和对照组各45例,试验组给予口服三七总皂苷缓释片,对照组则给予口服舒血宁片。结果试验组的总有效率（93.33%）高于对照组（66.67%）,且试验组不良反应的发生率（2.22%）低于对照组（28.89%）,差异均具有统计学意义（P〈0.05）。结论三七总皂苷缓释片治疗心脑血管疾病患者的疗效较好,且不良反应较少。

Objective To investigate the clinical effects of total saponins of Panax sustained-release tablets in the treatment of cardiovascular and cerebrovascular diseases. Methods 90 cases of patients with cardiovascular disease from October 2011 to October 2014 in our hospital were randomly divided into experimental group and control group of 45 cases, the experimental group received oral Panax notoginseng saponins slow release tablets, patients in the control group were treated with oral Shuxuening film. Results The total efficiency in experimental group（93.33%） was significantly higher than that in the control group（66.67%）, and the incidence of adverse reactions in the experimental group（2.22%） was significantly lower than that in the control group（28.89%）, the differences were statistically significant（P〈0.05）. Conclusion Panax total saponinsustained-release tablets therapy in patients with cardiovascular disease better, and fewer adverse reactions.